Table 1.
Baseline characteristics of patients in both groups. Data are mean ± s.e. or n (%) unless otherwise specified.
Variable | Group A | Group B | P-value |
---|---|---|---|
Age | 35.34 ± 4.7 | 35.35 ± 4.9 | 0.99 |
BMI (kg/m2) | 28.44 ± 6.8 | 28.11 ± 6.6 | 0.64 |
Diagnosis | 0.94 | ||
Male factor | 70 | 66 | |
Unexplained | 23 | 32 | |
Tubal factor | 43 | 45 | |
Ovulatory dysfunction | 58 | 51 | |
Endometriosis | 17 | 17 | |
Diminished ovarian reserve | 50 | 51 | |
Other | 15 | 14 | |
Endometrial thickness (mm) | 10.5 ± 2.1 | 10.3 ± 1.9 | 0.40 |
Estradiol level on CD 15 (pg/mL) | 925.7 ± 497.5 | 967.7 ± 528.5 | 0.46 |
Progesterone level on CD 16 (ng/mL) | 24.7 ± 116.6 | 24.4 ± 85.3 | 0.98 |
Trigger medication | |||
HCG | 178 | 160 | 0.18 |
Lupron | 39 | 52 | 0.13 |
Positive pregnancy test rate (%) | 139/249 (55.8) | 140/244 (57.3) | 0.40 |
Clinical pregnancy rate (%) | 117/249 (47) | 119/244 (48.7) | 0.36 |